Browsing by Author "Lopez, Emiliano S."
Now showing items 1-3 of 3
-
Corneal Neovascularization: A Combined Approach of Bevacizumab and Suramin Showed Increased Antiangiogenic Effect Through Downregulation of BFGF and P2X2
Lopez, Emiliano S.; Ortiz, Gustavo A.; Potilinski, Constanza.; Croxatto, Oscar.; Gallo, Juan E. (Current Eye Research, 2017-12-21)ABSTRACT Purpose: The objective is to analyze the antiangiogenic mechanism of suramab, a pharmaceutical compound of bevacizumab and suramin, in a rabbit model of corneal angiogenesis. Material and Methods: Corneal ... -
Evaluation of the Performance of an Ophthalmic Thermosensitive Hydrogel Containing Combination of Suramin and Bevacizumab.
Quinteros, Daniela A.; Lopez, Emiliano S.; Couto, Juan L.; Maletto, Belkys A.; Allemandi, Daniel A.; Palma, Santiago D.; Gallo, Juan E. (Bentham Science Publishers, 2016)Suramab (SUM) is a new pharmaceutical combination made up of suramine (SUR) and bevacizumab (BVM), which showed a high synergistic effect when administered jointly. As the pharmaceutical vehicle, poloxamer aqueous dispersions ... -
Evaluation of the Performance of an Ophthalmic Thermosensitive Hydrogel Containing Combination of Suramin and Bevacizumab.
Quinteros, Daniela.; Lopez, Emiliano S.; Couto, Juan L.; Maletto, Belkys A.; Allemandi, Daniel A.; Palma, Santiago D.; Gallo, Juan E. (Bentham Science Publishers, 2016)Suramab (SUM) is a new pharmaceutical combination made up of suramine (SUR) and bevacizumab (BVM), which showed a high synergistic effect when administered jointly. As the pharmaceutical vehicle, poloxamer aqueous dispersions ...